GEN Podcasts
de Genetic Engineering & Biotechnology News (GEN)
Precision Automation Meets Biology
À propos de ce podcast
Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition monthly and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN's unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, and commercialization.
GEN's print magazine, which also can easily be accessed online, includes feature articles on emerging technologies, product roundups, in-depth overviews from key scientific and bioindustry meetings, and industry-standard tutorials and technical articles on drug discovery, bioprocessing, and assay technologies.
Hosted on Acast. See acast.com/privacy for more information.
Épisodes
- Precision Automation Meets Biology · 42 min · Épisode 1Episode 1: Precision Automation Meets Biology Central question: How can automation help scientists move faster without losing sight of the biology? This opening episode would…
- Data Integrity as the Foundation for AI · 18 min · Épisode 2Artificial intelligence is advancing quickly into laboratory operations, which is why thinking about the quality and integrity of the supporting data early on is important. In…
- Small Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity, Speed, Scale-Up, and Sustainability · 34 min · Épisode 2Small molecules continue to play a major part in pharmaceutical development, but increasing molecular complexity, accelerated timelines, and evolving manufacturing and regulatory…
- Beyond the Technology: AI Readiness in Regulated Laboratories · 24 min · Épisode 1This episode establishes the broader context for AI adoption. Rather than focusing on AI tools themselves, the discussion explores what laboratories must have in place before AI…
- Enabling In Vivo Lentiviral Therapies: Manufacturing Strategies to Improve Purity, Scalability, and Clinical Readiness. · 35 min · Épisode 1Lentiviral vectors are gaining momentum not just as ex vivo tools but as potential in vivo therapeutic platforms. But with that shift comes a number of manufacturing challenges…
- The Future of Bioinformatics: Scaling Interactive and Computational Workflows with Seqera · 18 minSponsored by Seqera As data volumes in life sciences continue to grow, bioinformaticians and researchers are more dependent than ever on solutions that help them streamline…
- Smart Vector Design for Improved Cell and Gene Therapies · 1 h 0 minIn the episode, we’re talking about vector design and delivery for gene therapies. The field of cell and gene therapies is advancing, but there are still challenges with delivery…
- From Functional Genomics to Cell Therapy: The Role of CRISPR-based Gene Editing · 59 minThere are an estimated 6,000 Mendelian diseases, most of which still lack cures. Gene editing is an essential technology for studies aimed at generating data about…
- Precision Base Editing Meets Single-Cell Multiomics to Advance Cell and Gene Therapies · 33 minIn this episode, you’ll hear a group of experts discussing base editing and how the technology is helping scientists engineer powerful cell therapies for various diseases…
- Cas-CLOVER: An advanced gene editing technology capable of meeting crop improvement challenges · 32 minThis GENcast is the final installment in a 3-part series on Cas-CLOVER, “the proven alternative to CRISPR/Cas9,” sponsored by Demeetra AgBio. Demeetra has built extensive gene…
- The Possibilities of Cas-CLOVER and piggyBac · 35 minThis GENcast is part 2 of a 3-part series on Cas-CLOVER, “the proven alternative to CRISPR/Cas9,” sponsored by Demeetra AgBio. Demeetra has built extensive gene editing know-how…
- Addressing Barriers in Gene Therapy · 13 minIn this podcast episode, join us as we delve into addressing regulatory challenges in gene therapy with María Orío, the Head of Regulatory Affairs at Viralgen. Learn about the…







